• SHARE

“It is guaranteed safe and effective,” says a voice with what’s probably meant to be a heavy Russian accent. “How do we know? Because it was tested on a bear, by a scientist who is also a bear.” This is an excerpt from a September edition of The Daily Show, and the subject was the Russian COVID-19 vaccine, Sputnik V. It hasn’t aged well: Now that a peer-reviewed article in The Lancet has established Sputnik as safe and effective, the initial failure of many countries to believe in it looks like a missed opportunity.

The list of countries ordering the Sputnik vaccine is now growing. But given that Russia approved Sputnik back in August, long before any other vaccine got the green light, why didn’t it achieve wider use more quickly? Why didn’t the European Union, which faces a massive vaccine shortage, order it along with other vaccines which also weren’t yet approved when the orders were being made?

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)